RUA Life Sciences (LON:RUA) Reaches New 52-Week Low at $41.50

RUA Life Sciences plc (LON:RUAGet Rating) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 41.50 ($0.51) and last traded at GBX 42 ($0.52), with a volume of 20109 shares changing hands. The stock had previously closed at GBX 43.50 ($0.54).

The firm’s 50-day moving average is GBX 47.99 and its 200-day moving average is GBX 77.65. The company has a debt-to-equity ratio of 5.20, a current ratio of 6.12 and a quick ratio of 5.93. The company has a market capitalization of £9.21 million and a P/E ratio of -3.85.

RUA Life Sciences Company Profile (LON:RUA)

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components.

Featured Articles

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.